MedTrace Logo

Treatment of Complex Femoropopliteal Artery Lesions Using Drug-coated PTA Balloon

NCT05616520 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 838

Last updated 2023-10-23

No results posted yet for this study

Summary

Although DCBs had been widely applicable after registration, there are still lack of clinical data and evidence in the real world condition of Chinese population. This data collection aims to perform regularly clinical follow up to guide the standardized diagnosis and treatment of patients post-operatively, in order to achieve the maximum clinical benefits of these patients, as well as improve the development of the field of peripheral artery disease treated by drug-coated balloon.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

drug-coated balloon

The intervention relates to a drug-coated balloon catheter includes a balloon and cover the drug-coated balloon surface.

Sponsors & Collaborators

  • Changhai Hospital

    collaborator OTHER

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • Second Affiliated Hospital of Suzhou University

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • RenJi Hospital

    collaborator OTHER

  • The Affiliated Hospital of Qingdao University

    collaborator OTHER

  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER

  • Chengdu University of Traditional Chinese Medicine

    collaborator OTHER

  • Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • Huashan Hospital

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-05-31
Completion
2025-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05616520 on ClinicalTrials.gov